Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), College of Chemistry and Molecular Sciences, Wuhan University , Wuhan 430072, P. R. China.
Department of General Surgery, China Resources & WISCO General Hospital , Wuhan, 430080, P. R. China.
ACS Appl Mater Interfaces. 2017 Sep 6;9(35):29547-29553. doi: 10.1021/acsami.7b09336. Epub 2017 Aug 25.
The first appeal of clinical assay is always accurate and rapid. For alkaline phosphatase (ALP) monitoring in medical treatment, a rapid, reliable surface-enhanced Raman scattering (SERS) test kit is designed based on a "hot spots" amplification strategy. Consisting of alkyne-tagged Au nanoparticles (NPs), Ag, and enzyme substrate, the packaged test kit can achieve one-step clinical assay of ALP in human serum within several minutes, while the operation is simple as it directly inputs the sample into the test kit. Here, Ag ions are adsorbed onto the surface of Au core due to electrostatic interaction between Ag and the negatively charged donor surface, then enzymatic biocatalysis of ALP triggers the reduction of Ag and subsequently silver growth occurs on every Au core surface in a controllable manner, forming "hot spots" between the Au core and Ag shell, in which the SERS signal of alkyne Raman reporters would be highly amplified. Meanwhile, ALP mediates a redox reaction of Ag as well as the dynamic silver coating process so the increase of SERS intensity is well-controlled and can be recognized with increasing amounts of the targets. Instead of conventional NP aggregation, this leads to a more reproducible result. In particular, the distinct Raman emission from our self-synthesized alkyne reporter is narrow and stable with zero background in the Raman silent region, suffering no optical fluctuation from biosystem inputs and the detection results are therefore reliable with a limit of detection of 0.01 U/L (2.3 pg/mL). Along with ultrahigh stability, this SERS test kit therefore is an important point-of-care candidate for a reliable, efficacious, and highly sensitive detection method for ALP, which potentially decreases the need for time-consuming clinical trials.
临床检测的首要诉求始终是准确和快速。针对医疗用途中碱性磷酸酶(ALP)的监测,我们设计了一种基于“热点”放大策略的快速、可靠的表面增强拉曼散射(SERS)检测试剂盒。该试剂盒由炔基标记的金纳米粒子(AuNPs)、Ag 和酶底物组成,可在数分钟内实现人血清中 ALP 的一步式临床检测,操作简单,只需将样本直接输入检测试剂盒即可。在这里,Ag 离子通过 Ag 与带负电荷的供体表面之间的静电相互作用被吸附到 Au 核表面,然后 ALP 的酶促生物催化触发 Ag 的还原,随后 Ag 在每个 Au 核表面以可控的方式生长,在 Au 核和 Ag 壳之间形成“热点”,炔基拉曼报告分子的 SERS 信号在此得到高度放大。同时,ALP 介导 Ag 的氧化还原反应和动态银包覆过程,因此 SERS 强度的增加得到很好的控制,可以通过增加目标物的数量来识别。与传统的 NP 聚集不同,这导致了更可重复的结果。特别是,我们自合成的炔基报告分子的独特拉曼发射具有窄而稳定的特征,在拉曼静默区没有背景,不会受到生物系统输入的光学波动影响,因此检测结果可靠,检测限为 0.01 U/L(2.3 pg/mL)。除了超高稳定性外,这种 SERS 检测试剂盒因此成为了一种可靠、有效且高度敏感的 ALP 检测方法的重要即时检测候选方案,有可能减少对耗时的临床试验的需求。